Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
Clinical trial NCT02587221 · COMPLETED
Trial details
- NCT number
- NCT02587221
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2018-07-23
- Enrollment
- 6790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.